Advertisement

Topics

Pulmonary Hypertension Association Company Profile

19:33 EDT 19th March 2019 | BioPortfolio

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of an affected individual. The function of the heart and lungs is severely compromised, manifested by a limited exercise capacity, and, ultimately, a reduced life expectancy. Approximately 100,000 people in Europe and the United States are afflicted with either primary or secondary forms of the disease related to conditions or tissue disorders that affect the lungs, such as scleroderma, lupus, HIV/AIDS or congenital heart disease.


News Articles [1299 Associated News Articles listed on BioPortfolio]

Cardiac MRI shows potential for noninvasive pulmonary hypertension diagnosis

Cardiac MRI can accurately diagnose pulmonary hypertension (PH) without the invasiveness of right-sided heart catheterization (RHC), suggests a new study published in Radiology.

FDA grants special recognition to AI software used to diagnose rare form of hypertension

The FDA has granted a breakthrough device designation for an artificial intelligence (AI) pattern recognition software being developed by Bayer and Merck & Co. in New Jersey that can identify signs...

Bellerophon Provides Update on INOpulse Phase 2b Clinical Program for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

Bellerophon Therapeutics (Nasdaq:BLPH) a clinical-stage biotherapeutics company, today provided an update on the Company’s ongoing Phase 2b randomized, double-blind, placebo-controlled clinical stud...

Can cardiac MRI replace echocardiography for diagnosing pulmonary hypertension?

Cardiac MRI can accurately diagnose patients with pulmonary hypertension (PH), according to an Oct. 23 study published in Radiology. Results may help improve PH detection rates and enhance care for...

Analytics 4 Life, Actelion partner on pulmonary hypertension Dx

Analytics 4 Life and Actelion Pharmaceuticals have teamed up on diagnostics for pulmonary hypertension, including a 500-patie -More- 

Circassia gets US and Chinese rights to AIT's pulmonary hypertension system

AIT Therapeutics Inc. licensed Circassia Pharmaceuticals PLC commercial rights in the US and China to its AirNOvent cylinder free nitric oxide (NO) generator and phasic-flow delivery system for use in...

Actelion’s Opsumit improves pulmonary vascular resistance in trial of portopulmonary hypertension

Presented as a late-breaking oral presentation at the European Respiratory Society (ERS) meeting in France, the PORtopulmonary hypertension Treatment wIth maCitentan ─ a randOmized clinical trial (P...

Pulmonary hypertension secondary to congenital diaphragmatic hernia: factors and pathways involved in pulmonary vascular remodeling

Drugs and Medications [0 Results]

None

PubMed Articles [3842 Associated PubMed Articles listed on BioPortfolio]

Obesity and Pulmonary Hypertension.

Whether the present obesity epidemic will increase the prevalence of pulmonary hypertension over the next decades is unclear. We review the obesity-related mechanisms that may further the development ...

Doppler-defined pulmonary hypertension in sepsis and septic shock.

The association of pulmonary hypertension (PH) in patients with sepsis is lesser understood.

Pulmonary hypertension in patients with a history of intravenous drug use.

Pulmonary hypertension may be a consequence of intrinsic elevation in pulmonary vasculature resistance or complicate numerous other conditions affecting the cardiac and respiratory systems. In this re...

Progress in genetic research on primary pulmonary hypertension.

Primary pulmonary hypertension (PPH) consisting of hereditary pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension is an obstructive pulmonary hypertension caused by primary ...

Using clinical and genetic data to predict pulmonary hypertension in bronchopulmonary dysplasia.

Pulmonary hypertension significantly increases morbidity and mortality in infants with bronchopulmonary dysplasia. The frequency of single nucleotide polymorphisms in arginase-1 (ARG1 rs2781666) and d...

Clinical Trials [7289 Associated Clinical Trials listed on BioPortfolio]

Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years

This is an open-label, uncontrolled, prospective long-term observation of Specific Drug in the treatment of patients with pulmonary hypertension up to 4 years. 160 patients with primary (i...

Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension

The purpose of this study is to describe the epidemiology of pulmonary hypertension in individuals with HIV infection and to investigate its pathogenesis. We propose to conduct a prospecti...

Gene Mutations in Secondary Pulmonary Hypertension

As a pulmonary hypertension center, we have created a database that prospectively tracks patients with different forms of secondary pulmonary hypertension. Records include genetic analysi...

Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms

This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis. All patients atten...

Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension

Dyspnea is a major symptom in pulmonary arterial hypertension and people with the same haemodynamic have generally different degree of dyspnea in pulmonary arterial hypertension. The hyper...

Companies [1499 Associated Companies listed on BioPortfolio]

Pulmonary Hypertension Association (PHA)

Headquartered in Silver Spring, Md., PHA is the country’s leading organization connecting pulmonary hypertension patients, families, and medical professionals. Its mission is...

Pulmonary Hypertension Association

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of an affected individual. The...

Tenax Therapeutics, Inc. 

Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The Company has a wor...

Inverseon, Inc.

Inverseon's product development programs target significant unmet medical needs and major market opportunities in chronic pulmonary diseases such as asthma, COPD and pulmonary hyp...

Actelion Ltd

Dr. McLaughlin is currently the professor of medicine and director of the Pulmonary Hypertension Program in the Division of Cardiovascular Medicine at the University of Michigan in Ann Arbor, Michigan...

More Information about "Pulmonary Hypertension Association" on BioPortfolio

We have published hundreds of Pulmonary Hypertension Association news stories on BioPortfolio along with dozens of Pulmonary Hypertension Association Clinical Trials and PubMed Articles about Pulmonary Hypertension Association for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pulmonary Hypertension Association Companies in our database. You can also find out about relevant Pulmonary Hypertension Association Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Pulmonary Hypertension
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of affected individuals. Symptoms can range from mild breathles...


Corporate Database Quicklinks



Searches Linking to this Company Record